Business
Miners drive FTSE 100 up despite Fed probe worry
The FTSE 100 on Monday pushed close to recent record levels, while gold rocketed to a new high, as investors weighed renewed concerns about the US Federal Reserve’s independence.
The FTSE 100 index closed up 16.10 points, 0.2%, at 10,140.70.
The FTSE 250 index ended up marginally at 23,036.86, and the AIM All-Share was up 6.44 points, 0.8%, at 796.86.
On Sunday, US Federal Reserve chairman Jerome Powell said that the central bank had been served grand jury subpoenas from the Department of Justice threatening a criminal indictment.
Mr Powell said the subpoenas relate to his Senate Banking Committee evidence in June and ongoing renovations at the Fed headquarters.
But Mr Powell said: “Those are pretexts. The threat of criminal charges is a consequence of the Federal Reserve setting interest rates based on our best assessment of what will serve the public, rather than following the preferences of the president.”
Russ Mould, investment director at AJ Bell, said the probe “unnerved markets” and “raised questions” about what might happen to the Fed once Mr Powell steps down in May.
“There is a fear that (US President Donald) Trump is meddling too much with policies that are meant to be set independently,” he added.
Mr Powell claimed the moves are about “whether the Fed will be able to continue to set interest rates based on evidence and economic conditions, or whether instead monetary policy will be directed by political pressure or intimidation”.
Atakan Bakiskan, economist at Berenberg, said this marks the first time Mr Powell has “openly confronted” Mr Trump about the Fed’s independence.
He said: “A Fed that aligns more closely with politics could trigger higher-for-longer inflation, possibly negative real rates at the short end of the curve, elevated long-term borrowing rates and a weaker dollar.”
Analysts at Wells Fargo said: “While we do not believe this will alter the near-term course of monetary policy, it will make the next Fed chair’s job that much harder to build a consensus among the 19 members of the Federal Open Market Committee.”
Stocks in New York were mixed at the time of the London close on Monday.
The Dow Jones Industrial Average was down 0.2%, the S&P 500 was flat and the Nasdaq Composite advanced 0.2%.
The yield on the US 10-year Treasury was quoted at 4.19% on Monday, widened from 4.17% on Friday. The yield on the US 30-year Treasury was at 4.84%, stretched from 4.83%.
The pound was quoted at 1.3468 US dollars at the time of the London equities close on Monday, up from 1.3407 US dollars on Friday.
The euro was higher at 1.1677 US dollars from 1.1631 US dollars. Against the yen, the dollar was trading at 158.12 yen, up slightly from 158.06 yen.
Analysts at Wells Fargo said of the Fed probe: “Markets mostly took the news in stride, but the modest financial market moves thus far have been consistent with what we would expect to see when worries flare up about Fed independence: higher Treasury yields, a steeper yield curve, a weaker dollar and a rally in gold prices.”
On the FTSE 100, Fresnillo, up 6.5%, and Endeavour Mining, up 4.2%, jumped as the gold price hit a fresh high amid the proposed action against the Fed and heightened geopolitical uncertainty.
Gold shot up to 4,621.38 US dollars an ounce at Monday’s close, another record high, up against 4,504.56 US dollars on Friday.
Glencore gained 3.5% as the copper price gained, and on further reflection of a potential tie-up with Rio Tinto.
In European equities on Monday, the CAC 40 in Paris closed down slightly while the DAX 40 ended up 0.6% in Frankfurt, setting another all-time high.
In London, Barclays fell 2.5%, after Mr Trump called for a 10% cap on credit card interest rates.
“We will no longer let the American Public be “ripped off’ by Credit Card Companies that are charging Interest Rates of 20 to 30%,” he said on Truth Social.
Niklas Kammer, senior equity analyst at Morningstar, said: “This is especially sensitive for Barclays as the UK lender has been building out its exposure to the US credit card market over the last years and has further ambitions to grow its portfolio.
“The bank will publish its new strategy in February, which we expect to partially rely on growth in Barclays’ US business.
“As this topic develops, we think it is possible that Barclays may have to fine tune its messaging for February.”
Also heading downwards, Mondi, which fell 2.5% after being downgraded by Morgan Stanley, and Ashtead Group, down 2.9% after Bank of America lowered its rating to “underperform”.
Pearson climbed 1.1% as Citi initiated coverage with a “buy” rating after a period of weak performance by media stocks.
The broker thinks the current perception of the AI risk facing Pearson’s portfolio is “overdone”, and current levels present an “attractive entry point”.
Sage rose 2.0% as UBS upgraded the accountancy software provider to “buy”.
“We see 9%-plus growth as well underpinned and AI more of an opportunity than threat,” the Swiss bank said.
But British Land fell 3.8% as chief executive Simon Carter said he was stepping down.
Analysts at JPMorgan said: “The news comes as a negative surprise to us, with uncertainty at the C-Suite level rarely welcomed by the market.
“British Land has been one of the best performers in recent periods, we think this is partly given its clear strategy. Uncertainty is likely to remain for now too.”
On the FTSE 250, well received trading updates drove Oxford Nanopore and Plus 500 up 9.4% and 5.4% respectively.
Oxford Nanopore expects full year revenue slightly ahead of previous expectations, while Plus 500 said it expects to report forecast-topping 2025 results.
Brent oil traded at 63.55 US dollars a barrel at the time of the London equities close on Monday, up from 63.42 US dollars late Friday.
The biggest risers on the FTSE 100 were Fresnillo, up 228.0 pence at 3,734.0p, Endeavour Mining, up 162.0p at 4,056.0p, Glencore, up 15.8p at 468.5p, Diageo, up 44.5p at 1,674.5p, and Rio Tinto, up 129.0p at 6,135.0p.
The biggest fallers on the FTSE 100 were British Land, down 15.8p at 397.0p, IAG, down 13.1p at 411.0p, Severn Trent, down 86.0p at 2,821.0p, Ashtead, down 162.0p at 5,432.0p and Marks & Spencer, down 8.9p at 344.1p.
Tuesday’s local corporate calendar has half year results from Warhammer owner Games Workshop plus trading statements from housebuilder Persimmon and recruiter PageGroup.
Tuesday’s global economic calendar has US inflation figures and the BRC retail sales monitor in the UK.
Contributed by Alliance News.
Business
Interest rate cuts not on the horizon, Bank of England governor says
Reopening the Strait of Hormuz is “the best thing to do” to prevent interest rates rising, Bank of England governor Andrew Bailey has said.
In an interview on Thursday evening after the Bank’s Monetary Policy Committee (MPC) voted unanimously to leave the rate unchanged at 3.75%, Mr Bailey said any further cuts are “not on the horizon” as he hinted at possible hikes.
It is the first time that all members have voted the same way since September 2021.
Iran effectively closed the vital oil and gas shipping route after the US and Israel attacked the country, which has pushed up global prices.
Mr Bailey said the war in the Middle East is hitting petrol pumps now, will likely increase household energy costs in summer, and put pressure on food prices.
He told LBC’s Andrew Marr: “The duration of this problem is crucial.
“I would also say very clearly that the best way to solve this situation is not through monetary policy. It is through sorting out at the source of what’s going on.
“Frankly, reopening the Strait of Hormuz is the best thing to do. Get the energy market back on its normal footing, as it were.”
Asked if he has a message for US President Donald Trump, Israeli Prime Minister Benjamin Netanyahu, and “whoever’s in charge in Tehran”, Mr Bailey said: “The best thing we can do actually for the world economy… is to sort out the problem in terms of reopening the energy supply lines, because that is in the best interest of people in the world.”
UK military planners have joined the US Central Command to help formulate proposals for opening the Strait.
The MPC now expects Consumer Prices Index inflation to be around 3% in the second quarter of 2026, up from the 2.1% that had been forecast in February, with a potential rise in inflation up to 3.5% in the third quarter.
Mr Bailey was asked if he foresees, in the final two years of his term, the ambition to reduce inflation to at or below 2% being fulfilled.
He told the programme: “If you’d asked me this question three weeks ago, I was very optimistic on this.”
The governor added: “We are fully committed to the inflation target, and our job, frankly, is to deal with the shocks as they come along.
“I have to do that. I don’t wish them. I wish they were not happening, but they are and we will have to deal with them.”
He said the impact of the war will likely feed through into a higher Ofgem energy price cap from July.
It was put to Mr Bailey that the Middle East crisis comes at a time when the UK economy has already “not been growing strongly”.
He responded: “It is a very difficult time to have this happen, but frankly, any time would be pretty difficult to have this happen.
“This is a major shock to energy prices, and we have to deal with it.”
He said the “sustainable rate of growth” in the UK needs to be raised which could come from investment from pensions and artificial intelligence.
“I’m not starry-eyed about it, but it is probably the most likely area that we’re going to raise the growth rate of the economy and that’s important”, he said of AI.
The MPC signalled that if the conflict persists and has a bigger impact on UK prices, it would need to take a “more restrictive policy stance”, which indicates higher interest rates to control inflation.
The governor added: “The longer it goes on… I’m afraid to say, but it is rather an obvious point, the effect will be larger.”
He said that is why it is “imperative” that “everything is done that can be done to alleviate this effect”, adding: “That is the critical thing.”
Business
Video: The Effects of High Oil Prices
new video loaded: The Effects of High Oil Prices
By Ben Casselman, Sutton Raphael, James Surdam, Joey Sendaydiego, Estelle Caswell and June Kim
March 19, 2026
Business
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.
Tom Little | Reuters
The Food and Drug Administration on Thursday approved a higher-dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from chief rival Eli Lilly.
Novo expects to launch the higher, 7.2-milligram dose of Wegovy in April. The Danish drugmaker is positioning that version to better compete with Lilly’s obesity drug Zepbound, which has proven to be more effective at promoting weight loss than the standard, 2.4-milligram dose of Wegovy.
That higher efficacy has helped Zepbound become the preferred obesity medication among prescribers and patients, even though it entered the U.S. market later than Wegovy, and has solidified Lilly’s position as the dominant player in the space.
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial. The standard dose of Wegovy has shown around 15% weight loss on average in clinical trials.
“I think it really makes it more competitive, and it really reduces the delta there,” Dr. Jason Brett, principal U.S. medical head at Novo Nordisk, said in an interview Thursday ahead of the approval.
“But even more importantly, I think it just gives patients another option if they’re not reaching their targets, and achieving some of these higher weight losses for certain patients,” he added.
In a separate phase three trial on patients with obesity and Type 2 diabetes, high-dose Wegovy demonstrated an average weight loss of 14.1%. People with diabetes typically have a harder time losing weight than people without the condition.
It marks the first approval of a GLP-1 treatment under the FDA’s new national priority voucher plan that aims to cut drug review times to one to two months for companies the agency says are supporting U.S. national health priorities. The FDA launched the pilot plan in June.
-
Business1 week agoStock market crash today (March 12, 2026): Nifty50 opens below 23,600; BSE Sensex down over 900 points on continuing US-Iran war – The Times of India
-
Fashion1 week agoUK’s Topshop unveils Tolu Coker capsule collection
-
Business1 week agoUS ignites Iran war, but Gulf Arab states pay the price | The Express Tribune
-
Fashion1 week agoIndia’s textile recycling market may reach $3.5 bn by 2030: Report
-
Tech1 week agoMeta Developed 4 New Chips to Power Its AI and Recommendation Systems
-
Business1 week ago8th Pay Commission: How Much Will Central Govt Employees’ Salaries Rise? What We Know So Far
-
Sports1 week agoBangladesh crush Pakistan in ODI series opener | The Express Tribune
-
Entertainment1 week agoEd Sheeran makes surprising Benny Blanco confession after hygiene uproar
